Title: A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors.

Authors: Gollapudi, P; Hasegawa, L S; Eastmond, D A

Published In Mutat Res Genet Toxicol Environ Mutagen, (2014 Jun)

Abstract: Fisetin, a plant flavonol commonly found in fruits, nuts and vegetables, is frequently added to nutritional supplements due to its reported cardioprotective, anti-carcinogenic and antioxidant properties. Earlier reports from our laboratory and others have indicated that fisetin has both aneugenic and clastogenic properties in cultured cells. More recently, fisetin has also been reported to target Aurora B kinase, a Ser/Thr kinase involved in ensuring proper microtubule attachment at the spindle assembly checkpoint, and an enzyme that is overexpressed in several types of cancer. Here we have further characterized the chromosome damage caused by fisetin and compared it with that induced by two known Aurora kinase inhibitors, VX-680 and ZM-447439, in cultured TK6 cells using the micronucleus assay with CREST staining as well as a flow cytometry-based assay that measures multiple types of numerical chromosomal aberrations. The three compounds were highly effective in inducing aneuploidy and polyploidy as evidenced by increases in kinetochore-positive micronuclei, hyperdiploidy, and polyploidy. With fisetin, however, the latter two effects were most significantly observed only after cells were allowed to overcome a cell cycle delay, and occurred at higher concentrations than those induced by the other Aurora kinase inhibitors. Modest increases in kinetochore-negative micronuclei were also seen with the model Aurora kinase inhibitors. These results indicate that fisetin induces multiple types of chromosome abnormalities in human cells, and indicate a need for a thorough investigation of fisetin-augmented dietary supplements.

PubMed ID: 24680981

MeSH Terms: Aurora Kinase B/antagonists & inhibitors*; Benzamides/pharmacology*; Cell Line; Chromosomes, Human/genetics; Chromosomes, Human/metabolism; Flavonoids/pharmacology*; Flavonols; Humans; Micronuclei, Chromosome-Defective/chemically induced*; Piperazines/pharmacology*; Polyploidy*; Protein Kinase Inhibitors/pharmacology*; Quinazolines/pharmacology*